Trial intelligence / Profile preview

Carvedilol in treatment-naïve prostate cancer

NCT02944201Phase 2Unknown

Sponsor
Montefiore Medical Center
Start
Apr 2017
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of carvedilol in prostate adenocarcinoma, sponsored by Montefiore Medical Center. Status: unknown.

02

Drugs

carvedilol
03

Conditions

prostate adenocarcinoma

Beyond the preview

Go deeper on NCT02944201.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02944201.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call